"A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer
IGF-1 LR3 (Long R3 IGF-1, CAS 946870-92-4) is a recombinant 83-amino-acid analogue of insulin-like growth factor 1 with an N-terminal extension and Arg3 substitution, extending plasma half-life and reducing IGFBP binding
This product is designed to facilitate such high-level investigation, offering a reliable tool for laboratory professionals
Much of the data below is derived from animal models in which nutritional interventions garnered protection against acetaminophen and NSAID toxicity
2 Emergency Medicine Department, 3 Emergency and Critical Care Department, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia Abstract: A 51-year-old woman, who intentionally ingested a massive dose of ~60 g of valproic acid which she was using as a mood stabilizer for bipolar affective disorder, presented within 30 minutes of ingestion to the emergency department